+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Minimally Invasive Glaucoma Surgery Devices Market by Mechanism, End User, Distribution Channel, Indication - Global Forecast to 2030- Product Image
Minimally Invasive Glaucoma Surgery Devices Market by Mechanism, End User, Distribution Channel, Indication - Global Forecast to 2030- Product Image
Sale

Minimally Invasive Glaucoma Surgery Devices Market by Mechanism, End User, Distribution Channel, Indication - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968801
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Minimally Invasive Glaucoma Surgery Devices Market grew from USD 526.62 million in 2024 to USD 555.41 million in 2025. It is expected to continue growing at a CAGR of 5.42%, reaching USD 722.94 million by 2030.

Setting the Stage for a New Era in Glaucoma Care

In recent years, the management of glaucoma has been transformed by the advent of minimally invasive surgical options that promise effective intraocular pressure control with reduced risk profiles. As an executive audience, you require clarity on how these innovations are disrupting established treatment paradigms and influencing stakeholder behavior across clinical and commercial spheres.

This summary distills critical findings from a comprehensive analysis of procedural trends, device segmentation, tariff impacts and regional nuances. By mapping the evolving demand patterns and identifying strategic inflection points, it equips decision-makers with a nuanced understanding of where growth will materialize and how to position investments for maximum return. The sections that follow illuminate the forces reshaping glaucoma intervention, from technological breakthroughs to policy shifts, offering a cohesive framework to guide product development, market entry and competitive response strategies.

From Conventional Surgery to Precision-Guided Micro-Interventions

The glaucoma surgery landscape is undergoing a paradigm shift driven by the integration of micro-precision technologies and image-guided interventions. Surgeons now leverage high-resolution intraoperative guidance to navigate anatomical variations, ensuring precise stent placement and optimized outflow enhancement. Concurrently, the industry’s emphasis on patient-centric outcomes has elevated the role of less invasive approaches that shorten recovery times and improve quality of life.

Emerging materials and device geometries are enabling sustained efficacy while minimizing tissue disruption, spurring broader adoption across both early and advanced disease stages. These developments reflect a broader trend toward customization, where modular platforms and adaptable toolkits support a spectrum of clinical scenarios. As a result, minimally invasive procedures are no longer niche alternatives but core components of comprehensive glaucoma management pathways.

Navigating the Ripple Effects of 2025 US Tariff Adjustments

The introduction of revised US tariff schedules in 2025 has created a ripple effect across manufacturing, pricing and procurement strategies for glaucoma devices. Import duties on key components have increased landed costs, prompting manufacturers to reevaluate supply chain footprints and consider onshore assembly or alternative sourcing locations.

Procurement teams are balancing these cost pressures against clinical demand for best-in-class technologies, negotiating extended contracts and exploring bundled purchasing agreements to mitigate margin erosion. At the same time, domestic players are scaling capacity to capture market share from higher-cost imports, intensifying competition and accelerating product innovation cycles. These dynamics underscore the need for agility in pricing models and proactive engagement with payers to sustain adoption momentum.

Dissecting Demand Through Mechanism End-User Channel and Clinical Application

The market segmentation analysis reveals a multifaceted demand profile shaped by device mechanism, end-user setting, distribution pathways and clinical indication. On the mechanism front, canaloplasty approaches represented by systems such as iTrack and OMNI are gaining traction for their ability to restore natural aqueous outflow. Subconjunctival filtration solutions, exemplified by the Preserflo Microshunt and Xen Gel Stent, are positioned as alternatives for patients requiring sustained pressure reduction beyond trabecular interventions. Suprachoroidal shunts including the Cypass and iStent Supra are emerging as niche offerings that leverage uveoscleral pathways, while trabecular micro-bypass implants such as the Hydrus Microstent, iStent, Kahook Dual Blade and Trabectome address conventional outflow resistance directly.

Demand is driven by a diverse end-user mix spanning ambulatory surgery centers, hospital operating rooms and specialized ophthalmic clinics, each with unique volume drivers and procedural cost structures. The distribution landscape is split between direct tender agreements and established distributor networks, reflecting strategic choices around customer reach and pricing flexibility. Clinically, these devices serve patients across ocular hypertension, primary open-angle glaucoma and various forms of secondary glaucoma, ensuring that innovation trajectories align closely with evolving treatment algorithms.

Regional Variations Shaping Market Trajectories

Regional performance exhibits meaningful variations that reflect differences in healthcare infrastructure, reimbursement frameworks and disease burden. In the Americas, robust investments in ambulatory surgery centers and favorable payer coverage have fueled rapid uptake of advanced micro-invasive techniques. High procedure volumes and surgeon training programs further reinforce market maturity, positioning the region as a frontrunner in clinical adoption.

Europe, the Middle East and Africa present a more heterogeneous picture. Western European markets exhibit steady growth underpinned by centralized procurement and rigorous health technology assessments, while select Middle Eastern jurisdictions are accelerating infrastructure expansion to address rising glaucoma prevalence. In Africa, limited access to specialized care constrains uptake, yet pilot initiatives and philanthropic programs signal potential for long-term development.

The Asia-Pacific region is characterized by dynamic expansion in both developed markets and emerging economies. Governments are prioritizing ophthalmic health programs to manage the growing incidence of glaucoma, driving investment in training and facility upgrades. Local manufacturing initiatives and partnerships with global device suppliers are enhancing accessibility, laying the groundwork for sustained volume growth across diversified patient segments.

Competitive Landscape and Strategic Movers

Competitive dynamics are influenced by a mix of established multinationals and specialized device innovators. Leading ophthalmic firms are leveraging M&A to broaden their product portfolios, integrating complementary technologies that span canaloplasty, trabecular bypass and suprachoroidal shunting. At the same time, nimble med-tech startups are carving out niches by focusing on novel materials, enhanced delivery systems and digital integration for procedural planning.

Strategic alliances between manufacturers and surgical centers are redefining the commercialization model, with joint training programs and value-based agreements aligning incentives around clinical outcomes. Players that demonstrate consistent safety profiles, ease of adoption and demonstrable cost efficiencies are gaining preferential placement on hospital formularies and tender lists. As competitive intensity escalates, intellectual property fortification and life-cycle management strategies will be critical to sustaining market leadership.

Strategic Imperatives to Capitalize on Growth Avenues

Industry participants must adopt a multifaceted strategy to capitalize on growth opportunities. Prioritizing R&D investment in next-generation device platforms that integrate real-time feedback and digital analytics will differentiate offerings in a crowded market. Simultaneously, establishing localized manufacturing or assembly capabilities can mitigate tariff exposures and improve supply chain resilience.

Engagement with payers and health systems should emphasize real-world evidence demonstrating economic value, enabling more favorable reimbursement positioning. Strengthening partnerships with ambulatory surgery centers and training institutions will accelerate surgeon proficiency and drive procedural volumes. Finally, targeted patient education campaigns that highlight the benefits of minimally invasive approaches can foster demand at the grassroots level, creating a foundation for sustained market expansion.

Rigorous Multisource Research Underpinning Insights

The insights presented are underpinned by a rigorous research framework that synthesizes both primary and secondary sources. Extensive literature reviews of peer-reviewed journals, regulatory filings and industry white papers provided the foundational understanding of device technologies and clinical outcomes. In parallel, structured interviews with key opinion leaders, including glaucomatologists, surgical nurses and procurement managers, offered frontline perspectives on adoption drivers and implementation challenges.

Market participants were profiled through manufacturer disclosures, investor presentations and patent databases to assess competitive positioning and technology roadmaps. Data triangulation techniques ensured the validity of qualitative inputs, while thematic analysis of stakeholder feedback highlighted emerging trends. This comprehensive approach delivers robust, actionable insights tailored to strategic decision-making in the minimally invasive glaucoma surgery arena.

Synthesizing the Path Forward in Glaucoma Intervention

The evolution of minimally invasive glaucoma surgery devices is redefining clinical practice, regulatory environments and commercial strategies. As precision-guided micro-interventions become mainstream, stakeholders must navigate tariff fluctuations, segmentation complexity and regional disparities with agility. The competitive landscape is intensifying, rewarding those who blend innovation leadership with operational excellence.

By synthesizing mechanism-based demand, end-user dynamics, distribution nuances and indication requirements, this analysis provides a holistic vantage point for informed decision-making. Regional insights further contextualize growth prospects, while the strategic imperatives outlined chart a clear path for market entry, portfolio expansion and partnership formation. Ultimately, the future of glaucoma intervention will be shaped by the convergence of technological advancement, evidence-based validation and patient-centric delivery models.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Mechanism
    • Canaloplasty
      • iTrack
      • OMNI System
    • Subconjunctival Filtration
      • Preserflo Microshunt
      • Xen Gel Stent
    • Suprachoroidal Shunts
      • Cypass
      • Istent Supra
    • Trabecular Micro-Bypass
      • Hydrus Microstent
      • IStent
      • Kahook Dual Blade
      • Trabectome
  • End User
    • Ambulatory Surgery Centers
    • Hospital
    • Ophthalmic Clinics
  • Distribution Channel
    • Direct Tender
    • Distributor
  • Indication
    • Ocular Hypertension
    • Primary Open Angle Glaucoma
    • Secondary Glaucoma
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Alcon Inc.
  • Glaukos Corporation
  • Johnson & Johnson Vision Care, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Ivantis, Inc.
  • AbbVie Inc.
  • MicroSurgical Technology, Inc.
  • New World Medical, Inc.
  • Oertli Instrumente AG
  • Istar Medical S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Minimally Invasive Glaucoma Surgery Devices Market, by Mechanism
8.1. Introduction
8.2. Canaloplasty
8.2.1. iTrack
8.2.2. OMNI System
8.3. Subconjunctival Filtration
8.3.1. Preserflo Microshunt
8.3.2. Xen Gel Stent
8.4. Suprachoroidal Shunts
8.4.1. Cypass
8.4.2. Istent Supra
8.5. Trabecular Micro-Bypass
8.5.1. Hydrus Microstent
8.5.2. IStent
8.5.3. Kahook Dual Blade
8.5.4. Trabectome
9. Minimally Invasive Glaucoma Surgery Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospital
9.4. Ophthalmic Clinics
10. Minimally Invasive Glaucoma Surgery Devices Market, by Distribution Channel
10.1. Introduction
10.2. Direct Tender
10.3. Distributor
11. Minimally Invasive Glaucoma Surgery Devices Market, by Indication
11.1. Introduction
11.2. Ocular Hypertension
11.3. Primary Open Angle Glaucoma
11.4. Secondary Glaucoma
12. Americas Minimally Invasive Glaucoma Surgery Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Alcon Inc.
15.3.2. Glaukos Corporation
15.3.3. Johnson & Johnson Vision Care, Inc.
15.3.4. Santen Pharmaceutical Co., Ltd.
15.3.5. Ivantis, Inc.
15.3.6. AbbVie Inc.
15.3.7. MicroSurgical Technology, Inc.
15.3.8. New World Medical, Inc.
15.3.9. Oertli Instrumente AG
15.3.10. Istar Medical S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ITRACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OMNI SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRESERFLO MICROSHUNT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT SUPRA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HYDRUS MICROSTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY ISTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY KAHOOK DUAL BLADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECTOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OCULAR HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 55. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 56. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 58. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 59. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 63. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 104. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 105. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 106. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 112. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 113. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 128. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 129. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 131. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 132. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 136. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 137. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 138. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 168. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 169. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 184. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 185. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 187. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 188. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 192. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 193. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 216. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 217. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 218. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 224. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 240. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 242. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 248. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 249. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 251. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 252. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CANALOPLASTY, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUBCONJUNCTIVAL FILTRATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL SHUNTS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MICRO-BYPASS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC MINIMALLY INVASIVE G

Companies Mentioned

The companies profiled in this Minimally Invasive Glaucoma Surgery Devices market report include:
  • Alcon Inc.
  • Glaukos Corporation
  • Johnson & Johnson Vision Care, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Ivantis, Inc.
  • AbbVie Inc.
  • MicroSurgical Technology, Inc.
  • New World Medical, Inc.
  • Oertli Instrumente AG
  • Istar Medical S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 555.41 Million
Forecasted Market Value ( USD ) by 2030 $ 722.94 Million
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Glaucoma Aqueous Shunt Device Market by Device Type, End User, Distribution Channel, Material - Global Forecast to 2030 - Product Image

Glaucoma Aqueous Shunt Device Market by Device Type, End User, Distribution Channel, Material - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2025 - Product Image

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Glaucoma Surgery Devices - Global Strategic Business Report - Product Image

Glaucoma Surgery Devices - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Minimally Invasive Glaucoma Surgery Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) devices are a subset of surgical devices designed for the treatment of glaucoma, a chronic eye condition that leads to increased intraocular pressure (IOP) and can result in vision loss. These devices offer a less invasive alternative to traditional glaucoma surgeries, aiming to reduce IOP by improving aqueous humor outflow from the eye. MIGS procedures typically involve micro-scale incisions and implants, promising reduced recovery times and a lower risk of complications compared to conventional surgical methods. The market for MIGS devices overlaps with the broader ophthalmic surgical device market and aligns with an increasing demand for surgeries that provide symptom relief while minimizing tissue trauma. The development and adoption of MIGS devices have been influenced by technological advances, the rising prevalence of glaucoma, and the prioritization of patient quality of life and surgical outcomes. As a niche within surgical devices, MIGS products often require specialized training for surgeons and are accompanied by ongoing research and development to optimize their efficacy and safety profiles. In the market for MIGS devices, several companies are prominent, including Glaukos Corporation, Ivantis Inc., Alcon, a division of Novartis, and Johnson & Johnson Vision, a subsidiary of Johnson & Johnson. Other players include Allergan (now part of AbbVie), and New World Medical, which also contribute to the research, development, and distribution of these specialized surgical instruments for gl Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.